The Moving Average Convergence Divergence (MACD) for QTRX turned positive on November 09, 2026. Looking at past instances where QTRX's MACD turned positive, the stock continued to rise in 41 of 48 cases over the following month. The odds of a continued upward trend are 85%.
Following a +22.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where QTRX advanced for three days, in 209 of 262 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 121 of 144 cases where QTRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 84%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 53 cases where QTRX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 85%.
The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on QTRX as a result. In 75 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
QTRX moved below its 50-day moving average on November 11, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for QTRX crossed bearishly below the 50-day moving average on November 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where QTRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
QTRX broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.577) is normal, around the industry mean (4.142). P/E Ratio (-1.105) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.894) is also within normal values, averaging (40.124).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. QTRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QTRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The 10-day RSI Indicator for RVTY moved out of overbought territory on October 30, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 instances where the indicator moved out of the overbought zone. In 24 of the 31 cases the stock moved lower in the days that followed. This puts the odds of a move down at 77%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RVTY as a result. In 62 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.
The Moving Average Convergence Divergence Histogram (MACD) for RVTY turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 34 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 69%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RVTY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
RVTY broke above its upper Bollinger Band on October 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 66 cases where RVTY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
Following a +6.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where RVTY advanced for three days, in 200 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
The Aroon Indicator entered an Uptrend today. In 114 of 188 cases where RVTY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 61%.
The Tickeron Price Growth Rating for this company is 3 (best 1 - 100 worst), indicating outstanding price growth. RVTY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.394) is normal, around the industry mean (67.298). P/E Ratio (74.572) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (0.734) is also within normal values, averaging (3.473). Dividend Yield (0.002) settles around the average of (0.002) among similar stocks. P/S Ratio (5.656) is also within normal values, averaging (9.775).
The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RVTY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.
QTRX | RVTY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 17 | 78 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 30 Undervalued | 79 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 86 | |
PRICE GROWTH RATING 1..100 | 51 | 3 | |
P/E GROWTH RATING 1..100 | 17 | 9 | |
SEASONALITY SCORE 1..100 | 50 | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
QTRX's Valuation (30) in the Pharmaceuticals Major industry is somewhat better than the same rating for RVTY (79) in the Medical Specialties industry. This means that QTRX’s stock grew somewhat faster than RVTY’s over the last 12 months.
QTRX's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as RVTY (100) in the Medical Specialties industry. This means that QTRX’s stock grew similarly to RVTY’s over the last 12 months.
RVTY's SMR Rating (86) in the Medical Specialties industry is in the same range as QTRX (98) in the Pharmaceuticals Major industry. This means that RVTY’s stock grew similarly to QTRX’s over the last 12 months.
RVTY's Price Growth Rating (3) in the Medical Specialties industry is somewhat better than the same rating for QTRX (51) in the Pharmaceuticals Major industry. This means that RVTY’s stock grew somewhat faster than QTRX’s over the last 12 months.
RVTY's P/E Growth Rating (9) in the Medical Specialties industry is in the same range as QTRX (17) in the Pharmaceuticals Major industry. This means that RVTY’s stock grew similarly to QTRX’s over the last 12 months.
| QTRX | RVTY | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 77% |
| Stochastic ODDS (%) | 1 day ago 85% | 1 day ago 68% |
| Momentum ODDS (%) | 1 day ago 85% | 1 day ago 70% |
| MACD ODDS (%) | 1 day ago 85% | 1 day ago 69% |
| TrendWeek ODDS (%) | 1 day ago 87% | 1 day ago 67% |
| TrendMonth ODDS (%) | 1 day ago 88% | 1 day ago 66% |
| Advances ODDS (%) | 3 days ago 80% | 3 days ago 67% |
| Declines ODDS (%) | 1 day ago 88% | 1 day ago 67% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 64% |
| Aroon ODDS (%) | 1 day ago 84% | 1 day ago 61% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
QTRX’s FA Score shows that 2 FA rating(s) are green while RVTY’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
QTRX’s TA Score shows that 3 TA indicator(s) are bullish while RVTY’s TA Score has 3 bullish TA indicator(s).
QTRX (@Medical/Nursing Services) experienced а -0.66% price change this week, while RVTY (@Medical Specialties) price change was -0.74% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.76%. For the same industry, the average monthly price growth was -4.63%, and the average quarterly price growth was -1.72%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -4.83%. For the same industry, the average monthly price growth was -5.05%, and the average quarterly price growth was +38.36%.
QTRX is expected to report earnings on Mar 02, 2027.
RVTY is expected to report earnings on Feb 04, 2027.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Medical Specialties (-4.83% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
A.I.dvisor indicates that over the last year, QTRX has been loosely correlated with TWST. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if QTRX jumps, then TWST could also see price increases.
| Ticker / NAME | Correlation To QTRX | 1D Price Change % | ||
|---|---|---|---|---|
| QTRX | 100% | -7.93% | ||
| TWST - QTRX | 49% Loosely correlated | -7.22% | ||
| ILMN - QTRX | 49% Loosely correlated | -0.92% | ||
| RVTY - QTRX | 45% Loosely correlated | -0.53% | ||
| CRL - QTRX | 44% Loosely correlated | -0.90% | ||
| A - QTRX | 43% Loosely correlated | -0.52% | ||
More | ||||
A.I.dvisor indicates that over the last year, RVTY has been closely correlated with TMO. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if RVTY jumps, then TMO could also see price increases.
| Ticker / NAME | Correlation To RVTY | 1D Price Change % | ||
|---|---|---|---|---|
| RVTY | 100% | -0.53% | ||
| TMO - RVTY | 70% Closely correlated | -0.07% | ||
| A - RVTY | 64% Loosely correlated | -0.52% | ||
| AZTA - RVTY | 63% Loosely correlated | +20.80% | ||
| WAT - RVTY | 62% Loosely correlated | -0.97% | ||
| BIO - RVTY | 60% Loosely correlated | -0.12% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PABU | 77.17 | 1.03 | +1.35% |
| iShares Paris-Aligned Climate Optimized MSCI USA ETF (PABU) | |||
| TGLR | 39.18 | 0.39 | +1.00% |
| Wedbush LAFFER TENGLER New Era Value ETF (TGLR) | |||
| GDEC | 41.06 | 0.28 | +0.69% |
| FT Vest U.S. Equity Moderate Buffer ETF - December (GDEC) | |||
| ABOT | 43.06 | N/A | N/A |
| Abacus FCF Innovation Leaders ETF (ABOT) | |||
| ATTR | 96.21 | N/A | N/A |
| Arin Tactical Tail Risk ETF | |||